7 mg tirzepatide Zepbound 7.5 mg/0.5 mL injection (single-dose vial) Images Mounjaro (Tirzepatide) is a type of medication called a dual glucose Tirzepatide Injection (Pre-filled Syringe) |

Discussion In this database study, treatment with semaglutide (against sitagliptin, a placebo proxy) led to a reduced risk of MACE, and tirzepatide (against dulaglutide) demonstrated a similar risk reduction in patients at elevated cardiovascular risk with obesity and type 2 diabetes

Administration Instruct patients how to prepare and administer the correct dose of MOUNJARO and assess their ability to inject subcutaneously to ensure the proper administration of MOUNJARO

are breastfeeding or plan to breastfeed

soup) can be your greatest defense against Zepbound side effects

NICE requires at least 5% weight loss by 6 months to continue treatment 6

It also influences lipid metabolism, which is why tirzepatide users often see dramatic improvements in their cholesterol and triglyceride numbers